Zinc-finger-nucleases mediate specific and efficient excision of HIV-1 proviral DNA from infected and latently infected human T cells

X Qu, P Wang, D Ding, L Li, H Wang, L Ma… - Nucleic acids …, 2013 - academic.oup.com
X Qu, P Wang, D Ding, L Li, H Wang, L Ma, X Zhou, S Liu, S Lin, X Wang, G Zhang, S Liu…
Nucleic acids research, 2013academic.oup.com
HIV-infected individuals currently cannot be completely cured because existing antiviral
therapy regimens do not address HIV provirus DNA, flanked by long terminal repeats
(LTRs), already integrated into host genome. Here, we present a possible alternative
therapeutic approach to specifically and directly mediate deletion of the integrated full-length
HIV provirus from infected and latently infected human T cell genomes by using specially
designed zinc-finger nucleases (ZFNs) to target a sequence within the LTR that is well …
Abstract
HIV-infected individuals currently cannot be completely cured because existing antiviral therapy regimens do not address HIV provirus DNA, flanked by long terminal repeats (LTRs), already integrated into host genome. Here, we present a possible alternative therapeutic approach to specifically and directly mediate deletion of the integrated full-length HIV provirus from infected and latently infected human T cell genomes by using specially designed zinc-finger nucleases (ZFNs) to target a sequence within the LTR that is well conserved across all clades. We designed and screened one pair of ZFN to target the highly conserved HIV-1 5′-LTR and 3′-LTR DNA sequences, named ZFN-LTR. We found that ZFN-LTR can specifically target and cleave the full-length HIV-1 proviral DNA in several infected and latently infected cell types and also HIV-1 infected human primary cells in vitro . We observed that the frequency of excision was 45.9% in infected human cell lines after treatment with ZFN-LTR, without significant host-cell genotoxicity. Taken together, our data demonstrate that a single ZFN-LTR pair can specifically and effectively cleave integrated full-length HIV-1 proviral DNA and mediate antiretroviral activity in infected and latently infected cells, suggesting that this strategy could offer a novel approach to eradicate the HIV-1 virus from the infected host in the future.
Oxford University Press